Out-of-Pocket Costs and Payer Types for Buprenorphine Among US Youth Aged 12 to 19 Years

Andrew Terranella; Gery Guy Jr; Andrea Strahan; Christina Mikosz

doi:10.1001/jamapediatrics.2023.2376

Out-of-Pocket Costs and Payer Types for Buprenorphine Among US Youth Aged 12 to 19 Years

JAMA Pediatr. 2023 Oct 1;177(10):1096-1098. doi: 10.1001/jamapediatrics.2023.2376.

Authors

Andrew Terranella¹, Gery Guy Jr¹, Andrea Strahan¹, Christina Mikosz¹

Affiliation

¹ Division of Overdose Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.

No abstract available

Plain language summary

This cross-sectional study examines out-of-pocket costs and payer types for buprenorphine prescriptions filled for youth aged 12 to 19 years at US retail pharmacies.

MeSH terms

Adolescent
Analgesics, Opioid / economics
Buprenorphine* / economics
Buprenorphine* / therapeutic use
Child
Female
Health Expenditures* / statistics & numerical data
Health Expenditures* / trends
Humans
Male
Narcotic Antagonists / economics
Narcotic Antagonists / therapeutic use
Opiate Substitution Treatment / economics
Opioid-Related Disorders / economics
United States
Young Adult

Substances

Buprenorphine
Narcotic Antagonists
Analgesics, Opioid